Á lódáil...
Phase II Study of Everolimus and Letrozole in Patients With Recurrent Endometrial Carcinoma
PURPOSE: The phosphoinositol-3 kinase (PI3K) pathway is frequently dysregulated in endometrial cancer (EC). Hormonal manipulation leads to response in some patients with EC, but resistance derived from PI3K pathway activation has been documented. Targeting mammalian target of rapamycin (mTOR) may ov...
Na minha lista:
Foilsithe in: | J Clin Oncol |
---|---|
Main Authors: | , , , , , , , , , , , , |
Formáid: | Artigo |
Teanga: | Inglês |
Foilsithe: |
American Society of Clinical Oncology
2015
|
Ábhair: | |
Rochtain Ar Líne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4348638/ https://ncbi.nlm.nih.gov/pubmed/25624430 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.58.3401 |
Clibeanna: |
Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!
|